Cargando…

Hypertension, Antihypertensive Use and the Delayed‐Onset of Huntington's Disease

BACKGROUND: Hypertension is a modifiable cardiovascular risk factor implicated in neurodegeneration and dementia risk. In Huntington's disease, a monogenic neurodegenerative disease, autonomic and vascular abnormalities have been reported. This study's objective was to examine the relation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Steventon, Jessica J., Rosser, Anne E., Hart, Emma, Murphy, Kevin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2020
Materias:	Regular Issue Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7317197/ https://www.ncbi.nlm.nih.gov/pubmed/32017180 http://dx.doi.org/10.1002/mds.27976

Ejemplares similares

Hypertension, antihypertensive drugs, and age at onset of Huntington’s disease
por: Zhu, Yahui, et al.
Publicado: (2023)

A Critical Review of White Matter Changes in Huntington’s Disease
por: Casella, Chiara, et al.
Publicado: (2020)

Juvenile‐Onset Huntington Disease Pathophysiology and Neurodevelopment: A Review
por: Bakels, Hannah S., et al.
Publicado: (2021)

Altered cerebrovascular response to acute exercise in patients with Huntington’s disease
por: Steventon, Jessica J, et al.
Publicado: (2020)

Proenkephalin Decreases in Cerebrospinal Fluid with Symptom Progression of Huntington's Disease
por: Niemela, Valter, et al.
Publicado: (2020)

Disordered Decision Making: A Cognitive Framework for Apathy and Impulsivity in Huntington's Disease
por: Morris, Lee‐Anne, et al.
Publicado: (2022)

Hydrocephalus Complicating Intrathecal Antisense Oligonucleotide Therapy for Huntington's Disease
por: Stoker, Thomas B., et al.
Publicado: (2020)

Common Variants Coregulate Expression of GBA and Modifier Genes to Delay Parkinson's Disease Onset
por: Schierding, William, et al.
Publicado: (2020)

Clinical Outcomes and Selection Criteria for Prodromal Huntington's Disease Trials
por: Langbehn, Douglas R., et al.
Publicado: (2020)

Robust MR-based approaches to quantifying white matter structure and structure/function alterations in Huntington's disease
por: Steventon, Jessica J., et al.
Publicado: (2016)

Neurofilament Light Protein as a Potential Blood Biomarker for Huntington's Disease in Children
por: Byrne, Lauren M., et al.
Publicado: (2022)

Utility of the Huntington's Disease Prognostic Index Score for a Perimanifest Clinical Trial
por: Langbehn, Douglas R., et al.
Publicado: (2022)

Early Changes in Striatal Activity and Motor Kinematics in a Huntington's Disease Mouse Model
por: Koch, Ellen T., et al.
Publicado: (2022)

A Prion in yeast Huntington's disease
por: Dove, Alan W.
Publicado: (2002)

Does arterial hypertension influence the onset of Huntington's disease?
por: Valcárcel-Ocete, Leire, et al.
Publicado: (2018)

Multi-compartment analysis of the complex gradient-echo signal quantifies myelin breakdown in premanifest Huntington's disease
por: Casella, Chiara, et al.
Publicado: (2021)

CAG Somatic Instability in a Huntington Disease Expansion Carrier Presenting with a Progressive Supranuclear Palsy‐like Phenotype
por: Dewan, Ramita, et al.
Publicado: (2022)

Delayed onset of the diurnal melatonin rise in patients with Huntington’s disease
por: Aziz, N. Ahmad, et al.
Publicado: (2009)

Early grey matter changes in structural covariance networks in Huntington's disease
por: Coppen, Emma M., et al.
Publicado: (2016)

Emerging differences between Huntington's disease-like 2 and Huntington's disease: A comparison using MRI brain volumetry
por: Anderson, David G., et al.
Publicado: (2019)

Medical visits, antihypertensive prescriptions and medication adherence among newly diagnosed hypertensive patients in Korea
por: Jeong, Hyoseon, et al.
Publicado: (2017)

MIND and Mediterranean Diets Associated with Later Onset of Parkinson's Disease
por: Metcalfe‐Roach, Avril, et al.
Publicado: (2021)

Longitudinal in vivo MRI in a Huntington’s disease mouse model: Global atrophy in the absence of white matter microstructural damage
por: Steventon, Jessica J., et al.
Publicado: (2016)

The specific role of the striatum in interval timing: The Huntington’s disease model
por: Lemoine, Laurie, et al.
Publicado: (2021)

Cortical neurodevelopment in pre-manifest Huntington's disease
por: Kubera, Katharina M., et al.
Publicado: (2019)

Structural brain correlates of dementia in Huntington’s disease
por: Martinez-Horta, Saul, et al.
Publicado: (2020)

Age-at-onset in Huntington disease
por: Orth, Michael, et al.
Publicado: (2011)

Huntington's Disease Gene Hunters: An Expanding Tale
por: Rosser, Anne E., et al.
Publicado: (2021)

Suppression of Somatic Expansion Delays the Onset of Pathophysiology in a Mouse Model of Huntington’s Disease
por: Budworth, Helen, et al.
Publicado: (2015)

Cross-sectional and longitudinal voxel-based grey matter asymmetries in Huntington's disease
por: Minkova, Lora, et al.
Publicado: (2017)

Neocortical morphometry in Huntington's disease: Indication of the coexistence of abnormal neurodevelopmental and neurodegenerative processes
por: Mangin, Jean-Francois, et al.
Publicado: (2020)

Disease Onset in Huntington's Disease: When Is the Conversion?
por: Oosterloo, Mayke, et al.
Publicado: (2021)

Differential tractography as a dynamic imaging biomarker: A methodological pilot study for Huntington’s disease
por: Barrios-Martinez, Jessica V., et al.
Publicado: (2022)

Respiratory decline is integral to disease progression in Huntington's disease
por: Jones, Una, et al.
Publicado: (2016)

AHTPDB: a comprehensive platform for analysis and presentation of antihypertensive peptides
por: Kumar, Ravi, et al.
Publicado: (2014)

Dynamics of the connectome in Huntington's disease: A longitudinal diffusion MRI study
por: Odish, Omar F.F., et al.
Publicado: (2015)

Functional connectivity modeling of consistent cortico-striatal degeneration in Huntington's disease
por: Dogan, Imis, et al.
Publicado: (2015)

Complex spatial and temporally defined myelin and axonal degeneration in Huntington disease
por: Rosas, H.D., et al.
Publicado: (2018)

White matter cortico-striatal tracts predict apathy subtypes in Huntington's disease
por: De Paepe, Audrey E., et al.
Publicado: (2019)

Behavioral Deficits in Juvenile Onset Huntington’s Disease
por: Langbehn, Kathleen E., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_gt7d7g0chc0qkgl6s7lpnmoe4m